Browse By Region
Browse By Category
Recent News
By Region: North America
TB, HIV and malaria vaccine research gets major boost
(EurekAlert) Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.
- May 7, 2013
- | Filed under North America, Countermeasures, Policy & Initiatives, Public Health, and Research
Scientists Pursue New Therapies as Deadly H7N9 Flu Spreads in China
(GlobalBiodefense) Researchers from the University of Maryland School of Medicine have identified an experimental drug that has shown promise in treating influenza virus, and preventing lung injury and death from the virus.
- May 6, 2013
- | Filed under North America and Countermeasures
GE Crop Risk Assessment Challenges: An Overview
(FoodSafetyNews) There have been dramatic changes in the transgenic composition of GE corn and soybeans over the last five years, coupled with a substantial increase in reliance on pesticides and Bt toxins.
- May 6, 2013
- | Filed under North America, Policy & Initiatives, and Public Health
New federal investment could save millions of lives
(EurekAlert) Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives. The lab-on-a-chip (LOC), designed by Ash Parameswaran and his students, is among 102 global research projects receiving $100,000 each through the federal government’s Read More »
- May 3, 2013
- | Filed under North America and Research
Ebola’s secret weapon revealed
(EurekAlert) Researchers have discovered the mechanism behind one of the Ebola virus’ most dangerous attributes: its ability to disarm the adaptive immune system. University of Texas Medical Branch at Galveston scientists determined that Ebola short-circuits the immune system using proteins that work together to shut down cellular signaling related to interferon. Disruption of this activity, Read More »
- May 3, 2013
- | Filed under North America and Research